Profile: Emily Leproust: Revolutionizing DNA Syntheses

December
,
2015

Emily Leproust, CEO and co-founder of Twist Bioscience, is reinventing the wheel when it comes to DNA synthesis. “I have one goal with respect to DNA synthesis — that’s to make cloning obsolete,” she says.

Synthetic DNA can be used to modify the functionality of existing biological organisms such as yeast, bacteria, and algae. Editing the DNA of these organisms is a trial-and-error process, requiring dozens of iterations before the right DNA sequence is discovered. According to Leproust, many companies find it too cost prohibitive to try out enough combinations to get the right fit.

After working for years on products based on genetics and DNA sequencing, “I was very aware of how unhappy customers were in the DNA synthesis market,” says Leproust. “It takes too long to make DNA. It’s too expensive. People have more ideas than money.” Those without the resources to purchase DNA have to make it themselves, using a tedious cloning process in which host cells (e.g., yeast) churn out copies of inserted DNA. This is where Leproust’s company has found its niche — creating DNA faster and cheaper than the competition, and making DNA more available to those without a huge budget...
 

Would you like to access the complete CEP Article?

No problem. You just have to complete the following steps.

You have completed 0 of 2 steps.

  1. Log in

    You must be logged in to view this content. Log in now.

  2. AIChE Membership

    You must be an AIChE member to view this article. Join now.

Copyright Permissions: 

Would you like to reuse content from CEP Magazine? It’s easy to request permission to reuse content. Simply click here to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.